Targacept has launched a Phase 2 study of a drug it calls TC-5214 as a potential therapy for resistant hypertension.
136120
Targacept launches Phase 2 study
154789
Long before valtrex starts working
47238
MedNest incorporates and launches PharmaNest
96310
Hybrigenics starts phase II clinical trial of inecalcitol in chronic lymphocytic leukemia
140534
Bill would expand access to clinical trials
170196
Gene therapy can treat pulmonary hypertension:
1365
New drug strategy master plan being crafted --
56663
Device may treat high blood pressure
147662
Galenica's kidney drug meets endpoint in trial
70303
Amgen resumes cancer trial;
128603
Targanta submits Marketing Authorization Application for oritavancin
59485
Consortium supports next generation drug discovery
110203
A mysterious form of cell death uncovers prime suspect for new cancer drug development
38108
Drug for bones helps keep breast cancer from spreading
128394
Two new drugs can slash stroke risk
55572
XenoPort announces positive results of a Phase 1 clinical trial of XP21279
47275
Scientists discover molecular playbook to block cardiac hypertrophy